1. Home
  2. METCB vs PHAR Comparison

METCB vs PHAR Comparison

Compare METCB & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • METCB
  • PHAR
  • Stock Information
  • Founded
  • METCB 2015
  • PHAR 1988
  • Country
  • METCB United States
  • PHAR Netherlands
  • Employees
  • METCB N/A
  • PHAR N/A
  • Industry
  • METCB Coal Mining
  • PHAR Biotechnology: Pharmaceutical Preparations
  • Sector
  • METCB Energy
  • PHAR Health Care
  • Exchange
  • METCB Nasdaq
  • PHAR Nasdaq
  • Market Cap
  • METCB 397.7M
  • PHAR 951.7M
  • IPO Year
  • METCB N/A
  • PHAR N/A
  • Fundamental
  • Price
  • METCB $15.42
  • PHAR $14.60
  • Analyst Decision
  • METCB Strong Buy
  • PHAR Strong Buy
  • Analyst Count
  • METCB 3
  • PHAR 3
  • Target Price
  • METCB $21.67
  • PHAR $30.00
  • AVG Volume (30 Days)
  • METCB 71.7K
  • PHAR 12.7K
  • Earning Date
  • METCB 11-03-2025
  • PHAR 10-23-2025
  • Dividend Yield
  • METCB 5.32%
  • PHAR N/A
  • EPS Growth
  • METCB N/A
  • PHAR N/A
  • EPS
  • METCB N/A
  • PHAR N/A
  • Revenue
  • METCB $625,919,000.00
  • PHAR $339,836,000.00
  • Revenue This Year
  • METCB N/A
  • PHAR $16.63
  • Revenue Next Year
  • METCB $24.16
  • PHAR $6.77
  • P/E Ratio
  • METCB N/A
  • PHAR N/A
  • Revenue Growth
  • METCB N/A
  • PHAR 22.44
  • 52 Week Low
  • METCB $5.95
  • PHAR $7.31
  • 52 Week High
  • METCB $20.58
  • PHAR $17.08
  • Technical
  • Relative Strength Index (RSI)
  • METCB 50.76
  • PHAR 56.71
  • Support Level
  • METCB $15.14
  • PHAR $13.63
  • Resistance Level
  • METCB $16.41
  • PHAR $15.27
  • Average True Range (ATR)
  • METCB 0.80
  • PHAR 0.96
  • MACD
  • METCB -0.14
  • PHAR -0.13
  • Stochastic Oscillator
  • METCB 18.77
  • PHAR 51.83

About METCB Ramaco Resources Inc. Class B

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: